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The phosphoinositide phosphatase PTEN is mutated in many human cancers.
Although the role of PTEN has been studied extensively, the relative contri-
butions of its numerous potential downstream effectors to deregulated growth
and tumorigenesis remain uncertain.We provide genetic evidence inDrosophila
melanogaster for the paramount importance of the protein kinase Akt [also
called protein kinase B (PKB)] in mediating the effects of increased phospha-
tidylinositol 3,4,5-trisphosphate (PIP3) concentrations that are caused by the
loss of PTEN function. A mutation in the pleckstrin homology (PH) domain of
Akt that reduces its afﬁnity for PIP3 sufﬁced to rescue the lethality of ﬂies
devoid of PTEN activity. Thus, Akt appears to be the only critical target activated
by increased PIP3 concentrations in Drosophila.
Mutations in the tumor suppressor gene
PTEN (the phosphatase and tensin homolog
on chromosome 10) are frequent in glioblas-
tomas, endometrial carcinoma, melanomas,
and prostate cancer (1). Furthermore, two
dominant hamartoma syndromes, Cowden
disease and Bannayan-Zonana syndrome, are
linked to germ line mutations in PTEN (1).
The PTEN protein carries a phosphatase do-
main resembling those of dual-specificity
protein phosphatases (2–4 ). Although it can
dephosphorylate protein substrates such as
focal adhesion kinase (5) and the adapter
protein Shc (6 ), PTEN’s predominant enzy-
matic activity appears to be the dephospho-
rylation of phosphoinositides at the D3 posi-
tion. Because PTEN uses the second messen-
ger PIP3 as a substrate, PTEN antagonizes
the function of phosphatidylinositol-3 kinase
(PI3K) (7, 8). Immortalized mouse embryon-
ic fibroblasts or embryonic stem cells lacking
PTEN function show an approximately two-
fold increase in PIP3 concentrations (9, 10).
PIP3 interacts with a wide variety of PH
domain-containing proteins, including the
serine-threonine kinases Akt (also called
PKB) and phosphoinositide-dependent kinase
1 (PDK1), Btk family tyrosine kinases, gua-
nine nucleotide exchange factors for the Rho
and Arf families of small guanosine triphos-
phatases, and phospholipase C (11, 12). The
plethora of proteins that are potentially regu-
lated by PIP3 provides widespread signaling
potential for this lipid second messenger.
Genetic analyses in model organisms have
implicated PTEN as a negative regulator of
insulin receptor signaling. In the nematode
Caenorhabditis elegans, PTEN antagonizes
the activity of the PI3K AGE-1 in the regu-
lation of metabolism, development, and life
span (13–16 ). In the fruit fly Drosophila
melanogaster, PTEN counteracts signaling
downstream of the insulin receptor to control
cellular growth (17–19). There are, however,
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Fig. 1. Reduced kinase
activity caused by an
amino acid substitution
in the PH domain of
dAkt. (A) Effect of the
G99S substitution in
the PH domain on dAkt
kinase activity from lar-
val extracts (42). Activ-
ity from wild-type lar-
vae was considered to
be 100%. Inset, dAkt
protein was detected in 40 g of larval extracts using the same antiserum. (B) Reduced insulin-induced
activation of the G99S mutant dAkt. The dAkt constructs were expressed in HEK 293 cells (43).
Transfected cells were starved for 24 hours before stimulation with insulin for the indicated time
periods, and dAkt kinase activity was determined (44). The activity of wild-type dAkt from unstimulated
cells was considered to be relative activity  1.
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additional phenotypes associated with muta-
tions in PTEN that cannot easily be recon-
ciled with an exclusive function of PTEN in
insulin receptor signaling [for example, the
burst vulva phenotype in C. elegans (13) and
defects in the actin cytoskeleton in Drosoph-
ila (17 )]. To better understand the conse-
quences of loss of PTEN function, it would
be useful to know which important down-
stream effectors react to increased PIP3 con-
centrations and whether PTEN has other
physiological substrates in addition to PIP3.
The protein kinase Akt is an important
component of insulin receptor signaling (20).
Akt is recruited to the plasma membrane by
virtue of the interaction of its NH2–terminally
located PH domain with PIP3. At the mem-
brane, subsequent phosphorylation events by
PDK1 and an unidentified kinase lead to the
full activation of Akt (21–23). In PTEN-
deficient mouse embryonic fibroblasts and
embryonic stem cells, Akt is phosphorylated
and activated (9, 10). The phenotypes asso-
ciated with Akt mutations in both C. elegans
and Drosophila are consistent with its role in
signal transduction downstream of the insulin
receptor (24–27 ).
We monitored three properties of Dro-
sophila Akt (dAkt) separately: kinase activi-
ty, abundance of the protein, and membrane
localization. We relied entirely on mutations
in the endogenous gene encoding dAkt to
avoid potential side effects caused by over-
expression of mutant proteins. dAkt1 en-
codes a catalytically inactive protein,
dAktF327I (25). The viable dAkt4226 allele
contains a P-element insertion upstream of
the dAkt gene and therefore results in the
reduced expression of wild-type dAkt pro-
tein (19, 28). Finally, we characterized the
viable hypomorphic mutation dAkt3 (29)
that selectively impairs the membrane re-
cruitment of dAkt in response to increased
concentrations of PIP3. Sequencing of
genomic DNA extracted from dAkt3 ho-
mozygous flies revealed a single nucleotide
exchange resulting in the substitution of a
serine residue for a nonconserved glycine
at the end of the sixth  sheet of the PH
domain. To address the mechanism by
which this Gly99 3 Ser99 (G99S) mutation
in the PH domain affects dAkt, we com-
pared the amount of dAkt protein and ac-
tivity in wild-type and dAkt3 mutant larvae.
Whereas no apparent difference in expres-
sion of the protein was observed (Fig. 1A,
inset), dAkt activity from the mutant larvae
represented only 30% of that in wild-type
larval extracts (Fig. 1A). We also expressed
epitope-tagged forms of wild-type dAkt,
catalytically inactive dAktF327I, and PH
domain mutant dAktG99S in insulin-re-
sponsive human embryonic kidney (HEK)
293 cells. All three proteins were expressed
in similar amounts (30). dAktG99S activity
from insulin-stimulated cells was reduced
by about 90% as compared to that of the
wild-type kinase (Fig. 1B). All forms of
dAkt proteins were detected in the cytosol
of unstimulated cells (Fig. 2, A, D, and G).
Stimulation of the cells with insulin for 5
min resulted in association of the wild-type
and the catalytically inactive enzymes with
the plasma membrane, but failed to recruit
the dAktG99S mutant protein (Fig. 2, B, E,
and H). In contrast, treatment of HEK 293
cells with the protein-tyrosine phosphatase
inhibitor pervanadate, a potent activator of
Akt (31), led to membrane recruitment of
all dAkt proteins (Fig. 2, C, F, and J).
Fig. 2. Reduced mem-
brane localization of
the G99S mutation of
dAkt. HEK 293 cells
plated on coverslips
were transfected with
epitope-tagged wild-
type (A to C), G99S (D
to F), and F327I (G to J)
dAkt and deprived of
serum for 16 hours be-
fore stimulation with
insulin (B, E, H) or per-
vanadate (C, F, J) for 5
min. Fixed and perme-
abilized cells were incu-
bated ﬁrst with the
monoclonal antibody
12CA5 to the HA
epitope and then with
ﬂuorescein isothiocya-
nate–conjugated sec-
ondary antibody. An
analysis by confocal mi-
croscopy revealed the
subcellular localization
of the dAkt variants.
Fig. 3. Restored viability of ﬂies lacking dPTEN function by the PH
domain mutation in dAkt. (A) Morphology and weight of dPTEN mutant
ﬂies rescued by dAkt3/dAkt1. The left panel shows female ﬂies, the middle
panel shows male ﬂies, and the right panel shows the weight of adult
male ﬂies. (B) PIP3 concentrations in ﬂies devoid of dPTEN function
rescued by the dAkt3 mutation.
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Consistently, pervanadate treatment stimu-
lated dAktG99S activity to 80% of the
wild-type level. However, pervanadate-in-
duced activation of the mutant protein oc-
curred more slowly than did that of the
wild-type kinase (30). Taken together,
these data indicate that the G99S substitu-
tion reduces the association of dAkt with
the plasma membrane, probably by affect-
ing the affinity of its PH domain for PIP3.
Thus, dAkt3 enabled us to study the conse-
quences of impaired recruitment of dAkt to
the plasma membrane.
We combined the dAkt alleles with null
mutations in dPTEN (32). Animals lacking
dPTEN function die during larval stages. A
reduction in dAkt expression using the viable
dAkt4226 allele did not rescue the lethality
associated with dPTEN. Similarly, animals
doubly mutant for dPTEN and dAkt1 did not
survive. Thus, either dAkt activation is not
the sole reason for the lethality caused by loss
of PTEN, or dAkt function is not dispensable
in the absence of dPTEN. The latter hypoth-
esis is strongly supported by results obtained
with the dAkt allele that selectively impairs
the membrane recruitment of dAkt. Flies de-
void of functional dPTEN were rescued to
viability by any dAkt allelic combination that
included dAkt3 (Fig. 3A) (33). The rescued
flies did not display morphological defects
that would be expected in light of the pheno-
types ascribed to clones of dPTEN mutant
cells (17 ). Tangential sections through com-
pound eyes revealed essentially normal om-
matidial and rhabdomeric structures, and the
wings of the rescued flies showed no abnor-
malities in the venation, such as missing
crossveins (34 ). We determined the PIP3/
PIP2 ratio by metabolic labeling of phospho-
lipids from larvae (35). PIP3 concentrations
were increased in the dPTEN dAkt doubly
mutant larvae as compared to those of wild-
type larvae (Fig. 3B), excluding the possibil-
ity that PIP3 concentrations remain within
physiological limits by a feedback regulation
mechanism involving dAkt. This suggests
that the potential activation of a number of
PH domain–containing proteins other than
dAkt does not interfere with viability.
Our results indicate that the activation of
dAkt is the only crucial outcome of the loss
of dPTEN function. Activation of dAkt
should therefore mimic the dPTEN loss-of-
function phenotype. We expressed a consti-
tutively activated membrane-anchored dAkt
during eye development (36 ). The resulting
eyes were increased in size due to enlarged
ommatidia (Fig. 4B), a phenotype similar to
that seen in clones of dPTEN mutant cells
(17–19). This overgrowth phenotype is inde-
pendent of upstream signals, because it was
still evident in a chico or Dp110/PI3K mutant
background (Fig. 4D) (34 ).
We conclude that flies devoid of the tu-
mor suppressor dPTEN can live with abnor-
mally high concentrations of PIP3 if only the
affinity of dAkt for PIP3 is decreased. Thus,
the PH domain–mediated translocation of
dAkt to the membrane and its subsequent
activation is the only lethal event triggered by
increased PIP3 concentrations. Because the
PH domain of Akt interacts with the substrate
of PTEN’s lipid phosphatase activity, we also
conclude that PTEN does not exert any es-
sential function other than the dephosphoryl-
ation of PIP3.
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